These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34954328)

  • 1. Organoid and microfluidics-based platforms for drug screening in COVID-19.
    Ramezankhani R; Solhi R; Chai YC; Vosough M; Verfaillie C
    Drug Discov Today; 2022 Apr; 27(4):1062-1076. PubMed ID: 34954328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening.
    Kronemberger GS; Carneiro FA; Rezende DF; Baptista LS
    Artif Organs; 2021 Jun; 45(6):548-558. PubMed ID: 33264436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Organoids as a Promising Platform for Fighting COVID-19.
    Chen D; Su X; Chen H; Chen S; Zhao Y; Wei W
    Int J Biol Sci; 2022; 18(3):901-910. PubMed ID: 35173525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into organoid-based modeling of COVID-19 pathology.
    Boroojerdi MH; Al Jabry T; Mirarefin SMJ; Albalushi H
    Virol J; 2023 Feb; 20(1):37. PubMed ID: 36841795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human organoid models to study SARS-CoV-2 infection.
    Han Y; Yang L; Lacko LA; Chen S
    Nat Methods; 2022 Apr; 19(4):418-428. PubMed ID: 35396481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery.
    Giani AM; Chen S
    Stem Cell Res; 2021 May; 53():102207. PubMed ID: 33677394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Organoids as Model to Study SARS-CoV-2 Infection.
    Peng L; Gao L; Wu X; Fan Y; Liu M; Chen J; Song J; Kong J; Dong Y; Li B; Liu A; Bao F
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Microfluidic Technologies in Organoid Research.
    Liu H; Gan Z; Qin X; Wang Y; Qin J
    Adv Healthc Mater; 2024 Aug; 13(21):e2302686. PubMed ID: 38134345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Applications of separation technology in novel coronavirus research, epidemic prevention and detection].
    Li L; Zhu C; Zhao X; Qu F
    Se Pu; 2021 Jul; 39(7):679-685. PubMed ID: 34227364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids.
    Ng JH; Sun A; Je HS; Tan EK
    Neuroscientist; 2023 Feb; 29(1):30-40. PubMed ID: 34036855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling.
    Kim SK; Kim YH; Park S; Cho SW
    Acta Biomater; 2021 Sep; 132():37-51. PubMed ID: 33711526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models.
    Basu A; Pamreddy A; Singh P; Sharma K
    J Mol Biol; 2022 Feb; 434(3):167213. PubMed ID: 34437890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
    Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
    mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting.
    de Melo BAG; Benincasa JC; Cruz EM; Maricato JT; Porcionatto MA
    Biomed J; 2021 Mar; 44(1):31-42. PubMed ID: 33602633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological features of SARS-CoV-2 infection and relationships with organoid technology.
    İnanç İ; Erdemli E
    J Int Med Res; 2021 Sep; 49(9):3000605211044382. PubMed ID: 34521239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells.
    Dawoody Nejad L; Julian LM
    Mol Biol Rep; 2023 Dec; 50(12):10627-10635. PubMed ID: 37740859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.
    Skardal A; Shupe T; Atala A
    Drug Discov Today; 2016 Sep; 21(9):1399-1411. PubMed ID: 27422270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
    Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
    Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the neurological implications of acute and long COVID using brain organoids.
    García-González L; Martí-Sarrias A; Puertas MC; Bayón-Gil Á; Resa-Infante P; Martinez-Picado J; Navarro A; Acosta S
    Dis Model Mech; 2023 Jul; 16(7):. PubMed ID: 37458167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.